June 26th, 2024: Study reveals GLP-1 drugs may cause bone density loss without exercise A recent study from the University of Copenhagen raises new concerns about GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, highlighting potential bone density loss
It may increase the blood-thinning effects of anticoagulants like Warfarin (Coumadin), requiring careful monitoring of prothrombin times and bleeding risks
Introducing The Myers for POTS Patients Tailored for Needs, Designed for Results The Myers IV package is a powerhouse combination that addresses the multifaceted needs of POTS patients
To address this, intestinal PEs based primarily on medium chain fatty acid (MCFA) structures have been investigated to transiently and reversibly increase paracellular permeability ( 10 ), for example, acts via multimodal mechanisms to enhance TJ permeability and increase mucosal uptake of peptides (Maher et al., 2023)
No room temperature storage (1825C) accelerates peptide degradation by 400600% compared to refrigeration
Reactive astrocytes undergo changes in their signaling pathways under pathological conditions Reactive astrocytes exhibit pathological changes, including enhanced glycolytic flux and excessive lactate accumulation